Financing Status. Formerly VC-backed. Primary Industry. Drug Delivery. Other Industries. Drug Discovery. Stock Exchange. Primary Office. What you see here scratches the surface Request a free trial. Want to dig into this profile? Merrimack Pharmaceuticals Stock Performance. Merrimack Pharmaceuticals Financials Summary. Public Fundamental Data provided by Morningstar, Inc.
Request a free trial. Merrimack Pharmaceuticals Comparisons. HQ Location. Total Raised. Post Valuation. Last Financing Details. Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicin. Cambridge, MA. Ut enim ad minim veniam, qu. Durham, NC. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui. Add Comparison.
Merrimack Pharmaceuticals Competitors Merrimack Pharmaceuticals Patents. Merrimack Pharmaceuticals Recent Patent Activity. Merrimack Pharmaceuticals Executive Team 15 Update this profile. Merrimack Pharmaceuticals Board Members Merrimack Pharmaceuticals Signals. Growth Rate 0. Weekly Growth 0. Size Multiple x Median. Even if later stage clinical trials are successful, unexpected concerns may arise from subsequent analysis of data or from additional data. Obstacles may arise or issues may be identified in connection with review of clinical data with regulatory authorities.
Additionally, each of Ipsen and Elevation Oncology are subject to the risk that they may not successfully commercialize these development programs.
Merrimack is also subject to the risk that it may not have funding sufficient for its foreseeable and unforeseeable operating expenses and capital expenditure requirements.
In addition, press releases and other public statements by Ipsen and Elevation Oncology may contain forward-looking statements. Merrimack undertakes no obligation to update or revise any forward-looking statements. The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces. Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Pharmaceutical and biotechnology companies with cancer therapy drug candidates. CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience.
You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.
Who Uses Us. Customer Love. Predict your next investment. Founded Year Market Cap 0. Stock Price 4. About Merrimack Pharmaceuticals Merrimack Pharmaceuticals NASDAQ: MACK is a biopharmaceutical company discovering, developing, and commercializing medicines paired with companion diagnostics for the treatment of serious diseases, with a focus on cancer. Predict your next investment The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
0コメント